Ramachandra G Naik

Title: Ramachandra G Naik: Innovator in Metabolic Disorder Treatments

Introduction

Ramachandra G Naik is a notable inventor based in Short Hills, NJ (US). He has made significant contributions to the field of medicine, particularly in the development of treatments for metabolic disorders. With a total of 3 patents to his name, Naik's work has the potential to impact the lives of many patients suffering from chronic conditions.

Latest Patents

Naik's latest patents focus on SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease (CKD). These inventions relate to certain SGLT-2 inhibitors, such as ertugliflozin or its co-crystals and pharmaceutically acceptable salts. The patents aim to treat and prevent metabolic disorders, including type 1 and type 2 diabetes mellitus or pre-diabetes, in patients with renal issues. Additionally, the inventions include methods for preventing neuronal damage following ischemic stroke and traumatic brain injury in animals through the administration of ertugliflozin.

Career Highlights

Throughout his career, Naik has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corp. and Pfizer Corporation. His experience in these organizations has contributed to his expertise in developing innovative treatments for complex health issues.

Collaborations

Naik has collaborated with several professionals in his field, including Elizabeth S Ommen and James Michael Rusnak. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Ramachandra G Naik's contributions to the field of metabolic disorder treatments highlight his innovative spirit and dedication to improving patient care. His work with SGLT-2 inhibitors represents a significant advancement in medical science, showcasing the importance of research and collaboration in the pursuit of better health solutions.